The macrophage activation marker sCD163 combined with markers of the Enhanced Liver Fibrosis (ELF) score predicts clinically significant portal hypertension in patients with cirrhosis.
| Image |  |
|---|---|
| Description | scientific article published on 7 April 2016 |
| Author/s |
author: Hendrik Vilstrup Thomas Damgaard Sandahl Juan Carlos García-Pagan Virginia Hernandez-Gea |
| Publication date | April 7, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |